Abstract:Nastiti Intan Permata Sari, Sarwo Handayani Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Bogor, West Java, Indonesia Correspondence: Nastiti Intan Permata Sari, National Research and Innovation Agency (BRIN), Cibinong Science Centre, Jl. Raya Jakarta - Bogor Km. 46, Cibinong, Bogor, West Java, Indonesia, Email View the original paper by Dr Almuqbil and colleagues We congratulate Almuqbil et al for successfully conducting their research study to assess the epidemiology and clinical features of Neurofibromatosis type 1 (NF-1) based on the newly published revised NF-1 diagnostic criteria and to evaluate complications of NF-1 including neurodevelopmental disorders. Findings from this study form a holistic discussion about the epidemiology and clinical features of Neurofibromatosis type 1 (NF-1). This study uses a combination of NF-1 cases identification to obtain an expeditious and accurate diagnosis especially important for therapeutic methodologies. 1 However, after reviewing this research carefully, we suggest adding a discussion regarding knowledge about the area sampled so the epidemiology can be mapped based on the sampling area. 2 Neurofibromatosis type 1 (NF-1) or Von Recklinghausen disease is one of the inheritable neurocutaneous disorders that harbinger risk for bone abnormalities, vasculopathy, and cognitive impairment. 3 Our suggestion is to add a research background regarding Neurofibromatosis type 1 (NF-1) in Saudi Arabia. Data on the incidence of Neurofibromatosis type 1 (NF-1) in general is needed to find case updates. 4 The data can also be compared with data of this study. Additional clinical features of Neurofibromatosis type 1 (NF-1) are complete but need to be reviewed regarding pediatric patients, especially young children who need attention. 5 We sincerely thank Almuqbil et al for their concern and look forward to continued efforts in the epidemiology of Neurofibromatosis type 1 (NF-1) autosomal-dominant genetic disorder cases. The authors would like to acknowledge all the researchers and Prof. Dr. Sunarno in the Center for Biomedical Research BRIN for their continuous support. The authors would also like to convey gratitude to the research team of Almuqbil et al for their valuable research report. The authors report no conflicts of interest in this communication. 1. Almuqbil M, Alshaikh FY, Altwaijri W, et al. Epidemiology and outcomes of neurofibromatosis type I (NF-I): multicenter tertiary experience. J Multidiscip Healthc . 2024;17:1303–1314. doi:10.2147/JMDH.S454921 2. Wolfertz N, Bohm L, Keitel V, et al. Epidemiology, management, and outcome of infection, sepsis and septic shock in a German emergency department (EpiSEP study). Front Med . 2022;9:997992. doi:10.3389/fmed.2022.997992 3. Adil A, Koritala T, Munakomi S, et al. Neurofibromatosis type 1. NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health; 2024. 4. Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A . 2010;152A(2):327–332. doi:10.1002/ajmg.a.33139 5. DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics . 2000;105(3 Pt 1):608–614. doi:10.1542/peds.105.3.608

Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study

Cognition and behavior in adults with neurofibromatosis type 1

The Lack of Ad Hoc Neuropsychological Assessment in Adults with Neurofibromatosis: A Systematic Review

Social cognition in adults with neurofibromatosis type 1

Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1

Psychiatric disorders in individuals with neurofibromatosis 1 in Denmark: A nationwide register-based cohort study

Genotype-Phenotype Correlations in Neurofibromatosis Type 1: A Single-Center Cohort Study

Developmental trajectories in infants and pre-school children with Neurofibromatosis 1

Drosophila Contributions towards Understanding Neurofibromatosis 1

Health Supervision for Children With Neurofibromatosis Type 1

Response to "Epidemiology and Outcomes of Neurofibromatosis Type 1 : Multicenter Tertiary Experience"

Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment

Reduced higher dimensional temporal dynamism in neurofibromatosis type 1

Social cognition in children with neurofibromatosis type 1

A Systematic Review of Diagnostic Modalities and Strategies for the Assessment of Complications in Adult Patients with Neurofibromatosis Type 1

Written language achievement in children and adolescents with neurofibromatosis type 1 and Plexiform Neurofibromas

Parent-child discrepancies in reports of child psychosocial functioning in neurofibromatosis type 1

Evaluation and Factors of Quality of Life Among Patients With Neurofibromatosis Type 1-Associated Craniofacial Plexiform Neurofibromas.

An evaluation of computerized attention and executive function measures for use with school age children with neurofibromatosis type 1

Clinical manifestations of neurofibromatosis type 1 – a diagnostic and management challenge

Profiling the Word Reading Abilities of School-Age Children with Neurofibromatosis Type 1